Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and why this meeting is so important in this space. The combination of ...

In people with HIV taking antiretroviral therapy, excessive visceral abdominal fat drives cardiovascular disease risk, even ...

An expert on the intersection of HIV and menopause, Bridgette J. Picou, LVN, ACLPN, The Well Project, explains the importance ...

The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, ...

For centuries, it was believed that tuberculosis spread primarily when a vulnerable person spent hours in a poorly ventilated space with someone who was infectious. But new findings suggest that much ...

Researchers at UW are pioneering long-acting injectable HIV therapies that have the potential to simplify and expand ...

Global progress against HIV is at risk as aid cuts could trigger millions of new infections and deaths, potentially setting ...

Conventional thinking held that enclosed spaces where people spent long periods of time together, were where most TB ...

Several new developments in long-acting therapies for HIV treatment and prevention were presented to delegates at last week's Conference on Retroviruses and Opportunistic Infections (CROI) in San ...

References Gianella Weibel S et al. Letermovir for CMV suppression improves immunologic and functional aging outcomes in treated HIV. Conference on Retroviruses and Opportunistic Infections, San ...

The findings were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 Annual Meeting. Previous research has suggested an increased risk for neuropsychiatric ...